KARRI KLOEPPING: Open Payments
NPI 1558759407 · STERLING, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 43 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $909
Food & beverage: $824Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $374 |
| Madrigal Pharmaceuticals | 7 | $193 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $117 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| ABBVIE INC. | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 4 | $36 |
| Gilead Sciences, Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $14 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, IQIRVO, RINVOQ, VOQUEZNA, OMVOH.
Industry payments across IL — which companies pay providers there.
